Relypsa Adds Venture Funds In Another Effort To Reach Phase III
This article was originally published in The Pink Sheet Daily
Executive Summary
Relypsa, spun out from Amgen in 2007, has raised a third round of financing in an effort to move its lead compound into late-stage development.